inTRAvent Medical

inTRAvent Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

inTRAvent Medical is a neuro-focused medical device company commercializing its FDA-cleared SOLOPASS® system, a portable neuro-navigation platform that combines 2D/3D ultrasound, AI, and trajectory guidance for bedside procedures like EVD placement. The technology, conceptualized at Penn State Hershey Medical Center, addresses a century-old procedural standard with high variability. The company is led by a team of neurosurgeons and medical device executives and is exploring expansion into adjacent applications such as hematoma evacuation for hemorrhagic stroke.

NeurosurgeryNeurocritical Care

Technology Platform

Portable neuro-navigation platform integrating 2D/3D ultrasound imaging, artificial intelligence, and trajectory guidance for bedside neurosurgical procedures.

Opportunities

The large, global volume of EVD procedures presents a direct market for improving a century-old standard of care with high variability.
Expansion into bedside hematoma evacuation for hemorrhagic stroke addresses an even larger unmet need in neurocritical care, potentially reducing risky patient transfers and improving intervention speed.

Risk Factors

Commercial adoption risk is high due to entrenched surgical practices and the need to demonstrate clear cost-benefit to hospitals.
Regulatory risk exists for pipeline expansion, and competition could intensify if large medical device companies enter the portable neuro-navigation space.

Competitive Landscape

The company competes against the entrenched standard of freehand EVD placement and traditional, bulky operating room-based surgical navigation systems from giants like Medtronic and Stryker. Its primary differentiation is portability and bedside usability, creating a niche currently underserved by major players.